Perspective Therapeutics, Inc.
CATX
$3.90
-$0.03-0.76%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.60% | -103.15% | -100.68% | -25.76% | -45.30% |
| Total Depreciation and Amortization | 87.84% | 194.49% | 366.45% | 141.45% | 141.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.84% | 91.49% | 102.12% | 70.68% | 313.51% |
| Change in Net Operating Assets | -94.46% | -123.50% | -104.95% | -101.53% | 1,084.85% |
| Cash from Operations | -350.88% | -12,031.18% | -357.06% | -302.67% | 50.44% |
| Capital Expenditure | 76.13% | 42.67% | -432.69% | -392.64% | -4,881.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.20% | -171.79% | -213.84% | -227.53% | -814.73% |
| Cash from Investing | 118.83% | -56.57% | -233.23% | -267.74% | -998.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -30.00% | -27.50% | -20.00% | 36.92% | 41.18% |
| Issuance of Common Stock | -93.81% | -93.60% | -93.32% | -93.43% | 18,128.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -96.44% | -96.32% | -96.16% | -20.43% | 36,764.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -159.34% | -195.87% | -199.84% | -192.64% | 543.73% |